Annual Operating Expenses
$132.75 M
+$39.64 M+42.57%
31 December 2023
Summary:
CymaBay Therapeutics annual total operating expenses is currently $132.75 million, with the most recent change of +$39.64 million (+42.57%) on 31 December 2023. During the last 3 years, it has risen by +$45.17 million (+51.57%).CBAY Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$42.55 M
+$10.35 M+32.13%
31 December 2023
Summary:
CymaBay Therapeutics quarterly total operating expenses is currently $42.55 million, with the most recent change of +$10.35 million (+32.13%) on 31 December 2023.CBAY Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +51.6% | +73.6% |
| 5 y5 years | +28.8% | +67.1% |
CBAY Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | at high |
CymaBay Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $132.75 M(+42.6%) | $42.55 M(+32.1%) |
| Sept 2023 | - | $32.21 M(+3.5%) |
| June 2023 | - | $31.11 M(+15.8%) |
| Mar 2023 | - | $26.88 M(+14.5%) |
| Dec 2022 | $93.11 M(+6.3%) | $23.48 M(+9.9%) |
| Sept 2022 | - | $21.36 M(-10.1%) |
| June 2022 | - | $23.77 M(-3.0%) |
| Mar 2022 | - | $24.50 M(-0.0%) |
| Dec 2021 | $87.58 M(+66.5%) | $24.51 M(+10.5%) |
| Sept 2021 | - | $22.19 M(-4.6%) |
| June 2021 | - | $23.27 M(+32.1%) |
| Mar 2021 | - | $17.62 M(+11.0%) |
| Dec 2020 | $52.60 M(-49.0%) | $15.87 M(+36.2%) |
| Sept 2020 | - | $11.65 M(+4.5%) |
| June 2020 | - | $11.15 M(-19.9%) |
| Mar 2020 | - | $13.93 M(-45.3%) |
| Dec 2019 | $103.08 M(+42.2%) | $25.47 M(-8.1%) |
| Sept 2019 | - | $27.71 M(+8.0%) |
| June 2019 | - | $25.65 M(+5.8%) |
| Mar 2019 | - | $24.25 M(+18.0%) |
| Dec 2018 | $72.50 M | $20.55 M(-2.7%) |
| Sept 2018 | - | $21.13 M(+17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $17.97 M(+39.9%) |
| Mar 2018 | - | $12.85 M(+34.4%) |
| Dec 2017 | $31.32 M(+22.4%) | $9.56 M(+49.6%) |
| Sept 2017 | - | $6.39 M(-16.2%) |
| June 2017 | - | $7.63 M(-1.5%) |
| Mar 2017 | - | $7.74 M(+15.8%) |
| Dec 2016 | $25.59 M(-1.2%) | $6.69 M(+18.1%) |
| Sept 2016 | - | $5.66 M(-10.7%) |
| June 2016 | - | $6.35 M(-7.9%) |
| Mar 2016 | - | $6.89 M(+17.8%) |
| Dec 2015 | $25.90 M(+7.9%) | $5.85 M(-13.1%) |
| Sept 2015 | - | $6.73 M(+2.8%) |
| June 2015 | - | $6.54 M(-3.4%) |
| Mar 2015 | - | $6.78 M(-10.9%) |
| Dec 2014 | $24.01 M(+155.5%) | $7.61 M(+37.5%) |
| Sept 2014 | - | $5.54 M(-3.7%) |
| June 2014 | - | $5.75 M(+12.4%) |
| Mar 2014 | - | $5.12 M(+48.1%) |
| Dec 2013 | $9.40 M(-30.3%) | $3.45 M(+149.2%) |
| Sept 2013 | - | $1.39 M(-35.3%) |
| June 2013 | - | $2.14 M(-11.3%) |
| Mar 2013 | - | $2.42 M |
| Dec 2012 | $13.49 M | - |
FAQ
- What is CymaBay Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for CymaBay Therapeutics?
What is CymaBay Therapeutics annual total operating expenses?
The current annual operating expenses of CBAY is $132.75 M
What is the all time high annual operating expenses for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual total operating expenses is $132.75 M
What is CymaBay Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CBAY is $42.55 M
What is the all time high quarterly operating expenses for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly total operating expenses is $42.55 M